Publications

Our leadership team has a combined total of peer-reviewed research papers exceeding 1000, with publications in prestigious journals such as Nature, Science, New England Journal of Medicine, and The Lancet. Our team's expertise in their respective fields is unmatched, and they bring a wealth of knowledge and experience to every project we undertake. Our commitment to excellence and innovation is evident in everything we do, and we are always looking for new and exciting research opportunities.

Please find below a small selection of our publications:

A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer’s Disease Diagnosis Using Targeted Proteomics and Machine Learning

Find out more

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

Find out more

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

Find out more

Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease.

Find out more

Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Find out more

The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome

Find out more

Diagnosis of congenital disorders of glycosylation type-I using protein chip technology

Find out more

Desmosterolosis: a new inborn error of cholesterol biosynthesis

Find out more